🔎 Trials Near Me

Akèy › Twoub depresif majè › Georgia › Atlanta

Etid klinik pou Twoub depresif majè nan Atlanta, GA

25 etid pou Twoub depresif majè ap chèche patisipan nan sit nan ak bò kote Atlanta (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

Ap rekriteFaz 3
  • CenExel - Atlanta Center for Medical Research, Atlanta
  • CenExel - iResearch Atlanta, Decatur · 6 mi lwen
Laj 18 a 74 · Tout sèks · Mizajou Oct 5, 2026 · NCT07592689

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

Ap rekriteFaz 3
  • CenExel iResearch, LLC, Decatur · 6 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Oct 5, 2026 · NCT07412756

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

Ap rekriteFaz 3
  • Agile Clinical Research Trials, LLC, Atlanta
Laj 18 a 74 · Tout sèks · Mizajou Oct 1, 2026 · NCT07573176

A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

Ap rekriteFaz 3
  • CenExel iResearch, LLC, Decatur · 6 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Oct 1, 2026 · NCT07775300

Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium

Ap rekrite
  • Emory Healthcare, Atlanta
Laj 22 a 85 · Tout sèks · Mizajou Sep 29, 2026 · NCT07594483

JAK Signaling in Depression

Ap rekriteFaz 2
  • Emory University, Atlanta
Laj 25 a 55 · Tout sèks · Mizajou Sep 28, 2026 · NCT07003997

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Ap rekriteFaz 3
  • The Emory Clinic, Atlanta
  • CenExeli Research LLC, Decatur · 6 mi lwen
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT05850689

A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

Ap rekriteFaz 3
  • Peachford Hospital-Atlanta Behavioral Research, Atlanta
Laj 12 a 17 · Tout sèks · Mizajou Sep 25, 2026 · NCT07227454

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Ap rekriteFaz 3
  • Advanced Discovery Research, Atlanta
  • Agile Clinical Research Trials, LLC, Atlanta
  • iResearch Atlanta LLC, Decatur · 6 mi lwen
Laj 18 a 74 · Tout sèks · Mizajou Sep 25, 2026 · NCT06559306

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

Ap rekriteFaz 2
  • Seaport Investigator Site, Atlanta
  • Seaport Investigator Site, Decatur · 6 mi lwen
Laj 18 a 65 · Tout sèks · Mizajou Sep 14, 2026 · NCT07065240

Leucine in Midlife Depression

Ap rekriteFaz 2
  • Emory University Hospital, Atlanta
Laj 35 a 65 · Tout sèks · Mizajou Sep 11, 2026 · NCT06580145

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

Ap rekriteFaz 3
  • Delricht Research, Atlanta
  • Emory University Brain Health Center, Atlanta
Laj 18 a 74 · Tout sèks · Mizajou Sep 8, 2026 · NCT07076407

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

Ap rekriteFaz 2
  • Draig Clinical Site, Decatur · 6 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT07610473

Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

Ap rekrite
  • Emory University Hospital, Atlanta
Laj 22 a 70 · Tout sèks · Mizajou Aug 28, 2026 · NCT06423430

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

Ap rekriteFaz 2
  • Draig Clinical Site, Atlanta
  • Draig Clinical Site, Decatur · 6 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Aug 26, 2026 · NCT07300969

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT06911112

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Ap rekriteFaz 3
  • Advanced Discovery Research, Atlanta
  • Synexus - Atlanta, Atlanta
Laj 18 a 74 · Tout sèks · Mizajou Aug 3, 2026 · NCT06775379

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

Ap rekriteFaz 2
  • Denali Health Atlanta, LLC, Stone Mountain · 13 mi lwen
Laj 18 a 64 · Tout sèks · Mizajou Jul 27, 2026 · NCT07115329

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

Ap rekriteFaz 3
  • Clinical Research Site, Atlanta
Laj 18 a 65 · Tout sèks · Mizajou Jul 24, 2026 · NCT07484217

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06966401

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

Ap rekriteFaz 2
  • Trialmed /ID# 277601, Atlanta
Laj 18 a 65 · Tout sèks · Mizajou Jun 15, 2026 · NCT07276997

Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With Ketamine

Ap rekriteFaz 1 bonèVolontè an sante akeyi
  • Emory University, Atlanta
Laj 18 a 65 · Tout sèks · Mizajou May 26, 2026 · NCT05327699

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

Ap rekriteFaz 2
  • CenExcel, Decatur · 6 mi lwen
Laj 18 a 65 · Tout sèks · Mizajou May 11, 2026 · NCT06524830

Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

Ap rekriteFaz 2
  • Autobahn Site #112, Decatur · 6 mi lwen
Laj 18 a 65 · Tout sèks · Mizajou Jan 20, 2026 · NCT06633016

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

Ap rekriteFaz 4
  • Clinical Research Site, Atlanta
Laj 18 a 65 · Tout sèks · Mizajou Jan 23, 2025 · NCT06223880

Etid Twoub depresif majè nan lòt vil

Lòt etid nan Atlanta

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.